Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases.
Masmoudi-Kouki O, Namsi A, Hamdi Y, Bahdoudi S, Ghouili I, Chuquet J, Leprince J, Lefranc B, Ghrairi T, Tonon MC, Lizard G, Vaudry D. Masmoudi-Kouki O, et al. Among authors: vaudry d. Front Endocrinol (Lausanne). 2020 Nov 4;11:566026. doi: 10.3389/fendo.2020.566026. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33250858 Free PMC article. Review.
The Heterogeneity of Response of PC12 Cells from Different Laboratories to Nerve Growth Factor and Pituitary Adenylate Cyclase-Activating Polypeptide Questions the Reproducibility of Studies Carried Out with Tumor Cell Lines.
Delage C, Breard-Mellin L, Thérésine C, Simioneck S, Lefranc B, Leprince J, Bénard M, Vaudry D. Delage C, et al. Among authors: vaudry d. Neuroendocrinology. 2023;113(2):216-230. doi: 10.1159/000518337. Epub 2021 Jul 9. Neuroendocrinology. 2023. PMID: 34348336
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.
Bahdoudi S, Ghouili I, Hmiden M, do Rego JL, Lefranc B, Leprince J, Chuquet J, do Rego JC, Marcher AB, Mandrup S, Vaudry H, Tonon MC, Amri M, Masmoudi-Kouki O, Vaudry D. Bahdoudi S, et al. Among authors: vaudry d, vaudry h. Cell Mol Life Sci. 2018 Jun;75(11):2075-2091. doi: 10.1007/s00018-017-2727-2. Epub 2017 Dec 20. Cell Mol Life Sci. 2018. PMID: 29264673 Free PMC article.
Comparison of the effects of PACAP-38 and its analog, acetyl-[Ala15, Ala20] PACAP-38-propylamide, on spatial memory, post-learning BDNF expression and oxidative stress in rat.
Ladjimi MH, Barbouche R, Ben Barka Z, Vaudry D, Lefranc B, Leprince J, Troadec JD, Ben Rhouma K, Sakly M, Tebourbi O, Save E. Ladjimi MH, et al. Among authors: vaudry d. Behav Brain Res. 2019 Feb 1;359:247-257. doi: 10.1016/j.bbr.2018.10.023. Epub 2018 Oct 19. Behav Brain Res. 2019. PMID: 30343054
Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.
Neveu C, Dulin F, Lefranc B, Galas L, Calbrix C, Bureau R, Rault S, Chuquet J, Boutin JA, Guilhaudis L, Ségalas-Milazzo I, Vaudry D, Vaudry H, Santos JS, Leprince J. Neveu C, et al. Among authors: vaudry d, vaudry h. Br J Pharmacol. 2014 Oct;171(19):4425-39. doi: 10.1111/bph.12808. Epub 2014 Sep 5. Br J Pharmacol. 2014. PMID: 24913445 Free PMC article.
192 results